Status:
COMPLETED
Lung Function Changes of Induced Asthma Children Treated With Inhaled MgSO4
Lead Sponsor:
Chongqing Medical University
Conditions:
Asthma
Eligibility:
All Genders
4-16 years
Phase:
NA
Brief Summary
As a non-selective bronchodilator, magnesium sulfate (MgSO4) is effective when administered intravenously in the treatment of the patients with acute severe asthma not responding to conventional thera...
Eligibility Criteria
Inclusion
- known cases of controlled bronchial asthma
- ≧4 years of age
- the result was positive after acetylcholine provocation test in follow-up visit
Exclusion
- had received corticosteroids (inhaled or systemic) or β2-agonists or theophyllines before the clinic day
- had fever (axillary temperature\>38.5℃)
- history of chronic disease like bronchopulmonary dysplasia or cystic fibrosis
- history of renal insufficiency and known allergy to acetylcholine, albuterol or magnesium
Key Trial Info
Start Date :
November 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2013
Estimated Enrollment :
330 Patients enrolled
Trial Details
Trial ID
NCT01856959
Start Date
November 1 2011
End Date
May 1 2013
Last Update
May 20 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center of Respiratory Disorders,Children's Hospital,Chongqing Medical University
Chongqing, Chongqing Municipality, China, 400014